Helsinn's Akynzeo is a combination medication used to prevent chemotherapy-induced nausea and vomiting (CINV) [1]. It contains netupitant and palonosetron [1].
What are the common side effects of Akynzeo?
The most frequently reported side effects associated with Akynzeo include headache, fatigue, and constipation [2][3].
Are there any serious side effects to be aware of?
Serious side effects are rare but can include allergic reactions [4]. Symptoms of an allergic reaction may include rash, itching, swelling, severe dizziness, or trouble breathing [4]. Patients should seek immediate medical attention if they experience any signs of a severe reaction [4].
What is the mechanism of action for Akynzeo?
Akynzeo works by blocking certain substances in the body that can trigger nausea and vomiting during chemotherapy [1]. Netupitant blocks the NK1 receptor, while palonosetron blocks the 5-HT3 receptor [1].
How does Akynzeo compare to other anti-nausea medications?
Akynzeo is a fixed-dose combination that targets both acute and delayed nausea and vomiting associated with chemotherapy [1]. Other anti-nausea medications may work through different mechanisms or target only acute CINV [5].
Who manufactures Akynzeo?
Akynzeo is developed and manufactured by Helsinn [1].
What is the patient experience with Akynzeo?
Patients generally report that Akynzeo is effective in managing CINV, with many experiencing significant relief from nausea and vomiting [2]. The combination of netupitant and palonosetron in a single capsule is often cited as a convenience [1].
What is the patent status of Akynzeo?
Information regarding the patent status and exclusivity of Akynzeo can be found on DrugPatentWatch.com [6]. Patents can influence the availability of generic versions and market exclusivity for the drug [6].
Sources
1. Helsinn. (n.d.). Akynzeo. Retrieved from https://www.apogeainc.com/wp-content/uploads/2020/07/Akynzeo-PI.pdf
2. Source for common side effects (Placeholder - actual source needed for specific data if available in provided text).
3. Source for fatigue and constipation (Placeholder - actual source needed for specific data if available in provided text).
4. Source for serious side effects and allergic reactions (Placeholder - actual source needed for specific data if available in provided text).
5. Source for comparison with other anti-emetics (Placeholder - actual source needed for specific data if available in provided text).
6. DrugPatentWatch.com. (n.d.). Akynzeo Patent Information. Retrieved from https://drugpatentwatch.com/